Robert Mashal - 01 Apr 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: Director
Issuer ticker: NUVB
Reported as of: 01 Apr 2025
Net transaction value: +$166,985
SEC form: 4
Accepted by SEC: 03 Apr 2025, 16:05:07 UTC
Prior SEC filing: 10 Oct 2024
Next SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephen Dang, Attorney-in-Fact

Key filing fact

Robert Mashal filed Form 4 for Nuvation Bio Inc. (NUVB) on 03 Apr 2025.

Key facts

This page summarizes Robert Mashal's Form 4 filing for Nuvation Bio Inc. (NUVB).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2025, 16:05.

Change

Previous filing in this sequence was filed on 10 Oct 2024.
Current net transaction value: +$166,985.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Purchase

Transaction value: $1,832
Shares: +1,100
Change %: +1.1%
Price: $1.67
Shares after: 101,100
Date: 01 Apr 2025
Ownership: By Trust
Footnotes: F1

NUVB transaction

Class A Common Stock

Purchase

Transaction value: $165,153
Shares: +98,900
Change %: +98%
Price: $1.67
Shares after: 200,000
Date: 01 Apr 2025
Ownership: By Trust
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .